FRA:Q8T's Gross Margin % is ranked better than 76.15% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs FRA:Q8T: 67.84
OrbusNeich Medical Group Holdings had a gross margin of 68.66% for the quarter that ended in Dec. 2025 => Durable competitive advantage
OrbusNeich Medical Group Holdings (FRA:Q8T) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
OrbusNeich Medical Group Holdings had a gross margin of 68.66% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
OrbusNeich Medical Group Holdings Gross Margin % Related Terms
OrbusNeich Medical Group Holdings Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings Gross Margin % Chart
FRA:Q8T vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Gross Margin % of 68.66% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is near median its historical median of 67.93. Over the past decade, OrbusNeich Medical Group Holdings' Gross Margin % has ranged from 65.58 to 69.76. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #192 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 23.9%.
Is OrbusNeich Medical Group Holdings' Gross Margin % too high?
OrbusNeich Medical Group Holdings' current Gross Margin % of 68.66% is near median its 10-year median of 67.93. Over the past 10 years, this metric has ranged from a low of 65.58 to a high of 69.76. The Medical Devices & Instruments industry median Gross Margin % is 52.07. OrbusNeich Medical Group Holdings' value of 68.66% is 31.9% above this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #192 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #192 out of 805 companies for Gross Margin %. This places OrbusNeich Medical Group Holdings in the top 24% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. OrbusNeich Medical Group Holdings' value of 68.66% is 31.9% above this benchmark. Historically, OrbusNeich Medical Group Holdings' own Gross Margin % has ranged from 65.58 to 69.76 over the past decade. While the company's 10-year median is 67.93 vs. the industry median of 52.07, OrbusNeich Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current Gross Margin % of 68.66% is 31.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current Gross Margin % is 68.66%, which is near median its own 10-year median of 67.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Gross Margin % of 68.66%. The stock's GF Value™ is €0.47, compared to a current price of €0.36 — trading 22.6% below its estimated fair value. The current Gross Margin % is 68.66%, which is near median its 10-year median of 67.93 and 31.9% above the Medical Devices & Instruments industry median of 52.07. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Gross Margin % is 68.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.36 is trading 22.6% below its estimated GF Value™ of €0.47.
Key valuation signals for FRA:Q8T:
Gross Margin %: 68.66% (near median its 10-year median of 67.93)
GF Value™: €0.47 vs. price of €0.36 (22.6% below fair value)
Industry Position: 31.9% above the Medical Devices & Instruments median (#192 of 805)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score
Get the complete analysis for FRA:Q8T
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
